Target intelligence / Profile preview

Acrolein and related reactive electrophiles (RCS)

Target
RCS
Molecular classification
Reactive Carbonyl Species, Electrophiles, Aldehydes, Other
01

Overview

Acrolein and related reactive electrophiles, collectively known as Reactive Carbonyl Species (RCS), are highly reactive alpha,beta-unsaturated aldehydes generated primarily through lipid peroxidation and the metabolism of certain drugs or environmental pollutants (PubChem CID 7847). These molecules possess a strong affinity for nucleophilic groups on proteins, DNA, and lipids, leading to the formation of stable covalent adducts via Michael addition or Schiff base reactions (PMID: 18457515). This chemical modification, termed carbonylation, results in protein dysfunction, DNA damage, and the activation of pro-inflammatory and pro-apoptotic pathways (PMID: 21723373). Pathologically, acrolein is a significant mediator of secondary injury in spinal cord trauma and plays a critical role in the demyelination process of Multiple Sclerosis (PMID: 24933103). Furthermore, acrolein is the primary causative agent of hemorrhagic cystitis following cyclophosphamide therapy (StatPearls: Mesna). Therapeutic intervention involves the use of scavenging agents, such as hydralazine or mesna, which contain nucleophilic moieties that compete with cellular targets to neutralize these electrophiles (PMID: 25653143). By sequestering these reactive species, scavengers mitigate oxidative damage and preserve cellular integrity across various neurodegenerative and inflammatory conditions.

Other names
2-propenalReactive Carbonyl Speciesalpha,beta-unsaturated aldehydesAcrylic aldehyde4-Hydroxynonenal (4-HNE)Malondialdehyde (MDA)
02

Mechanism of action

Direct chemical neutralization through nucleophilic scavenging, typically via Michael addition or Schiff base formation, to prevent the electrophiles from forming damaging adducts with cellular proteins and DNA.

03

Biological functions

ApoptosisCell deathOxidative stress mediationProtein carbonylationOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseInflammationSpinal cord injuryMultiple sclerosisHemorrhagic cystitisOther
05

Safety considerations

Potential for scavengers to react with essential endogenous nucleophilesOff-target effects of scavenger drugs such as hypotensionSystemic toxicity of high-dose scavengers
06

Interacting drugs

Hydralazine

5 more in the full profile.

07

Biomarkers

3-hydroxypropylmercapturic acid (3-HPMA)Acrolein-lysine adducts4-hydroxynonenal-protein adducts

Beyond the preview

Go deeper on Acrolein and related reactive electrophiles (RCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acrolein and related reactive electrophiles (RCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call